Published in Drug Week, May 4th, 2007
In January 2006, Phytopharm entered into an exclusive global agreement with Schering-Plough for the Company's canine skin health product, Phytopica(R). Under the terms of the agreement, Phytopharm is responsible for manufacturing Phytopica(R) whilst Schering-Plough is responsible for the global sales, marketing and distribution of Phytopica(R). In April 2006, Schering-Plough...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.